Private equity's supermarket sweep
The private-equity battle for Wm Morrison is intensifying now that it has accepted a bid from Fortress Investment. Matthew Partridge reports
“You wait ages for a bidder to emerge for one of the UK’s big supermarket chains, then three turn up at once”, says Dominic O’Connell on the BBC. Having recently turned down a takeover offer from US private-equity firm Clayton, Dubillier & Rice (CDR), Wm Morrison has just “wrong-footed” the market by announcing a deal with a group of investors led by Fortress Investment. At 254p a share it represents a 42% premium to the supermarket’s pre-bid share price. And a third private-equity group, Apollo, is “considering its own offer”.
The Fortress bid is certainly convenient for Wm Morrison’s board, say Nils Pratley in The Guardian. Not only did it get a better offer than CDR’s, but it also gives it the opportunity to claim the moral high ground by selling to an owner they claim has a “long-term approach to investing”. But Fortress is “not running a charity”, while its commitments to good behaviour, including “industry-beating pay rates for staff”, are “statements of intention” rather than legally binding “post-offer undertakings”.
Don’t count on principle overriding profits, says Aimee Donnellan on Breakingviews. Whatever Wm Morrison’s board decides, there’s always the possibility that a new investor could go behind their backs by mounting a hostile takeover (bypassing the board and appealing directly to shareholders). Back-of-the-envelope calculations suggest that a bidder could offer 300p and still make a “decent return” if they were “prepared to ignore some of the employee-friendly promises made by Fortress”. At that price, institutional investors may swallow their complaints that private-equity firms “fundamentally undervalue British companies and have little regard for the long-term health of the businesses they buy”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Whatever the outcome of the battle for Morrisons, the “supermarket sweep” is likely to continue, says Sam Chambers in The Sunday Times. Private-equity firms who lose out on this deal may target other supermarkets, attracted by their “stubbornly low share prices”, especially when set against “healthy cash generation and big property portfolios”. Technology companies, especially Amazon, could also join in the fun. In 2017 Amazon spent $13.7bn on US retailer Whole Foods and made an approach to Waitrose.
Which supermarket is next?
Of the remaining supermarkets, Sainsbury’s is most likely to be the next subject of a bidding war, says Laura Onita in The Daily Telegraph. Its assets are “underpriced and highly cash generative”, while it “still has a lot of fat to burn”, which gives any new investor plenty of room to increase profits further through cost-cutting. Billionaire investor Daniel Kretinsky, known as the “Czech Sphinx”, recently acquired a large shareholding in Sainsbury’s. While Kretinsky claims the deal is part of a strategy “to acquire minority stakes in companies that sell food”, the move has sparked speculation that it could be a prelude to a bid to take the grocer private.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Investing in a dangerous world: key takeaways from the MoneyWeek Summit
If you couldn’t get a ticket to MoneyWeek’s summit, here’s an overview of what you missed
By MoneyWeek Published
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
By Jamie Ward Published
-
How investors can use options to navigate a turbulent world
Explainer Options can be a useful solution for investors to protect and grow their wealth in volatile times.
By James Proudlock Published
-
Invest in Hilton Foods: a tasty UK food supplier
Hilton Foods is a keenly priced opportunity in an unglamorous sector
By Dr Matthew Partridge Published
-
HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
By Dr Matthew Partridge Published
-
Lock in an 11% yield with Sabre
Tips Sabre, a best-in-class company is undervalued due to low profits in the motor insurance industry. Should you invest?
By Rupert Hargreaves Published
-
James Halstead is a family firm going cheap but should you buy?
James Halstead will rebound from a weak patch, while tax changes would be a buying opportunity
By Jamie Ward Published